Bristol John W & Company Increased Nike (NKE) Holding, Jarislowsky Fraser LTD Has Trimmed By $2.90 Million Its Sanofi Adr (SNY) Position

June 19, 2017 - By Adrian Erickson

Jarislowsky Fraser Ltd decreased Sanofi Adr (SNY) stake by 21.7% reported in 2016Q4 SEC filing. Jarislowsky Fraser Ltd sold 72,505 shares as Sanofi Adr (SNY)’s stock rose 14.25%. The Jarislowsky Fraser Ltd holds 261,551 shares with $10.58M value, down from 334,056 last quarter. Sanofi Adr now has $119.95B valuation. The stock decreased 0.08% or $0.04 on June 16, reaching $47.73. About shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since June 19, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.

Bristol John W & Company Inc increased Nike Inc (NKE) stake by 27.03% reported in 2016Q4 SEC filing. Bristol John W & Company Inc acquired 319,049 shares as Nike Inc (NKE)’s stock declined 8.78%. The Bristol John W & Company Inc holds 1.50M shares with $76.21 million value, up from 1.18M last quarter. Nike Inc now has $81.67 billion valuation. The stock decreased 3.40% or $1.8 during the last trading session, reaching $51.1. About 3,072 shares traded. Nike Inc (NYSE:NKE) has declined 9.24% since June 19, 2016 and is downtrending. It has underperformed by 25.94% the S&P500.

Investors sentiment increased to 0.98 in Q4 2016. Its up 0.04, from 0.94 in 2016Q3. It improved, as 84 investors sold NKE shares while 443 reduced holdings. 112 funds opened positions while 405 raised stakes. 993.29 million shares or 0.55% less from 998.81 million shares in 2016Q3 were reported. 5,850 were accumulated by Accuvest Advsr. Riverhead Mgmt Lc owns 30,024 shares. Vantage Investment Advisors Ltd reported 8,330 shares or 0.17% of all its holdings. First Comml Bank Of Omaha holds 0.44% in Nike Inc (NYSE:NKE) or 137,944 shares. Advisor Prtnrs Ltd Llc owns 0.29% invested in Nike Inc (NYSE:NKE) for 18,906 shares. Bokf Na reported 103,727 shares or 0.17% of all its holdings. Allianz Asset Management Ag holds 970,516 shares or 0.04% of its portfolio. Homrich Berg owns 8,067 shares. 5,165 are owned by Tru Investment Advsr. Redwood Investments Ltd has 0% invested in Nike Inc (NYSE:NKE) for 75 shares. Lenox Wealth Advsr Inc holds 0.01% or 822 shares in its portfolio. Federated Pa has invested 0% in Nike Inc (NYSE:NKE). Investec Asset Mgmt Limited owns 107,504 shares or 0.03% of their US portfolio. Bancorpsouth has 7,406 shares for 0.04% of their portfolio. Bridgecreek Mngmt owns 118,730 shares.

Bristol John W & Company Inc decreased Netflix Inc (NASDAQ:NFLX) stake by 11,090 shares to 342,685 valued at $42.42 million in 2016Q4. It also reduced Roper Technologies Inc (NYSE:ROP) stake by 14,539 shares and now owns 367,510 shares. Comcast Corp New (NASDAQ:CMCSA) was reduced too.

Since January 3, 2017, it had 1 buy, and 9 sales for $48.27 million activity. SPRUNK ERIC D sold 50,000 shares worth $2.78 million. $10.48 million worth of Nike Inc (NYSE:NKE) was sold by Ayre David J. $7.09M worth of stock was sold by Slusher John F on Tuesday, January 3. Another trade for 1,000 shares valued at $56,301 was made by LECHLEITER JOHN C on Friday, March 24. On Wednesday, February 1 the insider PARKER MARK G sold $5.29M.

Among 39 analysts covering Nike Inc. (NYSE:NKE), 23 have Buy rating, 2 Sell and 14 Hold. Therefore 59% are positive. Nike Inc. had 137 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by B. Riley & Co on Wednesday, September 28 with “Neutral”. The stock of Nike Inc (NYSE:NKE) earned “Neutral” rating by B. Riley & Co on Friday, August 26. The firm has “Buy” rating given on Monday, December 28 by DA Davidson. The company was maintained on Wednesday, June 29 by Canaccord Genuity. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, June 1. The company was maintained on Wednesday, June 29 by Goldman Sachs. On Wednesday, September 28 the stock rating was maintained by Wells Fargo with “Market Perform”. The firm earned “Buy” rating on Wednesday, September 28 by UBS. UBS maintained Nike Inc (NYSE:NKE) rating on Monday, December 12. UBS has “Buy” rating and $61 target. The stock of Nike Inc (NYSE:NKE) has “Neutral” rating given on Monday, September 26 by B.riley.

Jarislowsky Fraser Ltd increased Becton Dickinson And Company (NYSE:BDX) stake by 42,722 shares to 894,017 valued at $148.00M in 2016Q4. It also upped Potash Corporation Of Sask Inc. (NYSE:POT) stake by 184,971 shares and now owns 18.90M shares. Diageo Plc Adr (NYSE:DEO) was raised too.

Among 10 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Sanofi-aventis Sa had 16 analyst reports since October 15, 2015 according to SRatingsIntel. JP Morgan maintained the shares of SNY in report on Friday, April 21 with “Neutral” rating. Barclays Capital upgraded Sanofi SA (ADR) (NYSE:SNY) on Thursday, May 12 to “Overweight” rating. Goldman Sachs initiated the shares of SNY in report on Monday, November 7 with “Neutral” rating. Piper Jaffray initiated Sanofi SA (ADR) (NYSE:SNY) on Friday, September 23 with “Neutral” rating. The firm has “Sell” rating given on Friday, March 31 by JP Morgan. The stock has “Overweight” rating by Morgan Stanley on Thursday, October 15. On Tuesday, September 13 the stock rating was upgraded by BNP Paribas to “Neutral”. As per Wednesday, April 12, the company rating was upgraded by JP Morgan. HSBC downgraded the shares of SNY in report on Tuesday, May 3 to “Hold” rating. The rating was downgraded by Bernstein on Monday, November 9 to “Mkt Perform”.

Analysts await Sanofi SA (ADR) (NYSE:SNY) to report earnings on August, 4. They expect $0.78 EPS, up 5.41% or $0.04 from last year’s $0.74 per share. SNY’s profit will be $1.96B for 15.30 P/E if the $0.78 EPS becomes a reality. After $0.76 actual EPS reported by Sanofi SA (ADR) for the previous quarter, Wall Street now forecasts 2.63% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: